Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement May 6, 2026 Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 May 6, 2026 Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated May 5, 2026 Share this story Facebook Twitter LinkedIn